What is an autologous hematopoietic stem cell transplantation (AHSCT)?
Autologous hematopoietic stem cell transplantation (ASHCT) is a type of
Transplantation, in which the person’s own stem cells in particular from peripheral
Blood be used. These cells are collected in advance, at temperatures below zero
Degree and after high-dose chemo or immunosuppressive
Therapy returned at a later date.
This is a treatment that has been established for more than three decades and that is clinically known for
haematological malignancies (such as lymphoma, leukemia) is allowed. Due to the
Transplantation of hematopoietic stem cells has gained the majority of patients
suffered from tumor blood diseases and were previously sentenced to rapid death, considerable
Chances of recovery.
As fundamental investigations have shown, the cause of the
Development of autoimmune diseases in an impairment of the cells of the
Immune system. It is not surprising that therapeutic methods come to the rescue
hematologic patients have also proven effective in multiple sclerosis.
Therefore, ASHCT is considered a new and promising therapy for patients with
Autoimmune diseases (AID), including multiple sclerosis (MS).